Insider Trading26 Sept 2026, 07:40 pm
Bacil Pharma Closes Trading Window for Insider Trading Compliance
AI Summary
Bacil Pharma Ltd has announced the closure of its trading window for designated persons, effective October 1st, 2026. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will reopen 48 hours after the conclusion of the Board of Directors' meeting, which is scheduled to consider the un-audited financial results for the quarter and half-year ended September 30th, 2026. The exact date of the Board Meeting will be communicated separately to the stock exchanges.
Key Highlights
- Trading window closed from October 1st, 2026.
- Closure is for designated persons under SEBI regulations.
- Window reopens 48 hours post-Board Meeting.
- Board Meeting to consider Q2/H1 FY27 financial results.
- Company to separately announce the Board Meeting date.
Price Impact
More from BACPHAR